+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 1lx5 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
タイトル | Crystal Structure of the BMP7/ActRII Extracellular Domain Complex | |||||||||
![]() |
| |||||||||
![]() | GROWTH FACTOR/GROWTH FACTOR RECEPTOR / LIGAND-RECEPTOR COMPLEX / GROWTH FACTOR-GROWTH FACTOR RECEPTOR COMPLEX | |||||||||
機能・相同性 | ![]() negative regulation of prostatic bud formation / negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis / negative regulation of glomerular mesangial cell proliferation / mesenchymal cell apoptotic process involved in nephron morphogenesis / positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis / TGFBR3 regulates activin signaling / positive regulation of hyaluranon cable assembly / Signaling by Activin / inhibin binding / chorio-allantoic fusion ...negative regulation of prostatic bud formation / negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis / negative regulation of glomerular mesangial cell proliferation / mesenchymal cell apoptotic process involved in nephron morphogenesis / positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis / TGFBR3 regulates activin signaling / positive regulation of hyaluranon cable assembly / Signaling by Activin / inhibin binding / chorio-allantoic fusion / inhibin-betaglycan-ActRII complex / metanephric mesenchyme morphogenesis / nephrogenic mesenchyme morphogenesis / activin receptor activity / Signaling by BMP / transforming growth factor beta receptor activity, type III / penile erection / embryonic skeletal joint morphogenesis / negative regulation of striated muscle cell apoptotic process / activin receptor activity, type II / neural fold elevation formation / positive regulation of activin receptor signaling pathway / sperm ejaculation / transforming growth factor beta receptor activity, type II / metanephric mesenchymal cell proliferation involved in metanephros development / mesenchyme development / ameloblast differentiation / positive regulation of epithelial cell differentiation / embryonic camera-type eye morphogenesis / Sertoli cell proliferation / monocyte aggregation / allantois development / mesonephros development / BMP receptor activity / embryonic skeletal system development / regulation of removal of superoxide radicals / hindbrain development / mesenchymal cell differentiation / pericardium morphogenesis / BMP receptor binding / transforming growth factor beta receptor activity, type I / activin receptor activity, type I / endocardial cushion formation / receptor protein serine/threonine kinase / pharyngeal system development / activin binding / heart trabecula morphogenesis / cellular response to BMP stimulus / branching involved in salivary gland morphogenesis / embryonic pattern specification / metanephros development / negative regulation of mitotic nuclear division / gastrulation with mouth forming second / regulation of nitric oxide biosynthetic process / positive regulation of heterotypic cell-cell adhesion / response to vitamin D / cartilage development / determination of left/right symmetry / embryonic limb morphogenesis / negative regulation of non-canonical NF-kappaB signal transduction / cardiac muscle tissue development / anterior/posterior pattern specification / positive regulation of dendrite development / ureteric bud development / Molecules associated with elastic fibres / regulation of branching involved in prostate gland morphogenesis / negative regulation of NF-kappaB transcription factor activity / branching morphogenesis of an epithelial tube / growth factor binding / cardiac septum morphogenesis / odontogenesis of dentin-containing tooth / dendrite development / mesoderm development / negative regulation of cell cycle / mesoderm formation / positive regulation of SMAD protein signal transduction / epithelial to mesenchymal transition / negative regulation of Notch signaling pathway / negative regulation of neuron differentiation / regulation of signal transduction / BMP signaling pathway / positive regulation of bone mineralization / positive regulation of osteoblast differentiation / positive regulation of epithelial to mesenchymal transition / Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 / coreceptor activity / positive regulation of brown fat cell differentiation / positive regulation of neuron differentiation / axon guidance / positive regulation of erythrocyte differentiation / protein serine/threonine kinase activator activity / neuron projection morphogenesis / cytokine activity / skeletal system development / PDZ domain binding / growth factor activity / response to peptide hormone / negative regulation of neurogenesis / male gonad development / osteoblast differentiation 類似検索 - 分子機能 | |||||||||
生物種 | ![]() ![]() ![]() | |||||||||
手法 | ![]() ![]() ![]() | |||||||||
![]() | Greenwald, J. / Groppe, J. / Kwiatkowski, W. / Choe, S. | |||||||||
![]() | ![]() タイトル: The BMP7/ActRII Extracellular Domain Complex Provides New Insights into the Cooperative Nature of Receptor Assembly 著者: Greenwald, J. / Groppe, J. / Gray, P. / Wiater, E. / Kwiatkowski, W. / Vale, W. / Choe, S. | |||||||||
履歴 |
| |||||||||
Remark 999 | SEQUENCE THE SEQEUNCE FOR ACVR2 IS TRUNCATED. THE PROTEIN IN THE CRYSTAL ENDS AT GLU 102. |
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 60.4 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 43.1 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
文書・要旨 | ![]() | 788.9 KB | 表示 | ![]() |
---|---|---|---|---|
文書・詳細版 | ![]() | 810.1 KB | 表示 | |
XML形式データ | ![]() | 15 KB | 表示 | |
CIF形式データ | ![]() | 18.6 KB | 表示 | |
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
-関連構造データ
-
リンク
-
集合体
登録構造単位 | ![]()
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 | ![]()
| ||||||||
単位格子 |
| ||||||||
詳細 | The second part of the biological assembly is generated by the two fold axis: y-x+1, y, -z+1 |
-
要素
#1: タンパク質 | 分子量: 15699.730 Da / 分子数: 1 / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() 発現宿主: ![]() ![]() 参照: UniProt: P18075 | ||
---|---|---|---|
#2: タンパク質 | 分子量: 12019.440 Da / 分子数: 1 Fragment: Extracellular Ligand Binding Domain, C-terminal truncation 由来タイプ: 組換発現 / 由来: (組換発現) ![]() ![]() ![]() | ||
#3: 多糖 | alpha-D-mannopyranose-(1-3)-[beta-D-mannopyranose-(1-4)][alpha-D-mannopyranose-(1-6)]beta-D- ...alpha-D-mannopyranose-(1-3)-[beta-D-mannopyranose-(1-4)][alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | ||
#4: 糖 | Has protein modification | Y | |
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 4.69 Å3/Da / 溶媒含有率: 73.79 % | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
結晶化 | 温度: 296 K / 手法: 蒸気拡散法, ハンギングドロップ法 / pH: 7 詳細: 1M sodium acetate, 0.1M imidazole, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 296K | ||||||||||||||||||||||||
結晶化 | *PLUS 温度: 23 ℃ | ||||||||||||||||||||||||
溶液の組成 | *PLUS
|
-データ収集
回折 | 平均測定温度: 100 K |
---|---|
放射光源 | 由来: ![]() ![]() ![]() |
検出器 | タイプ: ADSC QUANTUM 315 / 検出器: CCD / 日付: 2002年2月10日 |
放射 | モノクロメーター: Si 111 / プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 1.03 Å / 相対比: 1 |
反射 | 解像度: 3.3→30 Å / Num. all: 8320 / Num. obs: 8320 / % possible obs: 96.7 % / Observed criterion σ(F): 0 / Observed criterion σ(I): -3 / Biso Wilson estimate: 145 Å2 / Rsym value: 0.055 / Net I/σ(I): 16.5 |
反射 シェル | 解像度: 3.3→3.42 Å / Rsym value: 0.332 / % possible all: 98.6 |
反射 | *PLUS 最低解像度: 100 Å / Num. measured all: 31531 / Rmerge(I) obs: 0.055 |
反射 シェル | *PLUS % possible obs: 98.6 % / Rmerge(I) obs: 0.332 |
-
解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: ![]()
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.4 Å | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | Biso mean: 69.6 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 3.3→27.12 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LS精密化 シェル | 解像度: 3.3→3.386 Å / Total num. of bins used: 20 /
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化 TLS | 手法: refined / Refine-ID: X-RAY DIFFRACTION
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化 TLSグループ |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ソフトウェア | *PLUS 名称: REFMAC / バージョン: 5 / 分類: refinement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化 | *PLUS 最高解像度: 3.3 Å / 最低解像度: 100 Å / % reflection Rfree: 5 % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 | *PLUS
|